{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:17:40Z","timestamp":1790320660325,"version":"4.1.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"DOI":"10.1007\/s11926-026-01212-4","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:14:03Z","timestamp":1770884043000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["NOD2-Related Multisystem Inflammatory Disorders and Recent Advances"],"prefix":"10.1007","volume":"28","author":[{"given":"Di","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atika","family":"Dhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"John M.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naotomo","family":"Kambe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren","family":"Strober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingping","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"issue":"7","key":"1212_CR1","doi-asserted-by":"publisher","first-page":"4812","DOI":"10.1074\/jbc.M008072200","volume":"276","author":"Y Ogura","year":"2001","unstructured":"Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G. Nod2, a Nod1\/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem. 2001;276(7):4812\u20138.","journal-title":"J Biol Chem"},{"issue":"49","key":"1212_CR2","doi-asserted-by":"publisher","first-page":"19440","DOI":"10.1073\/pnas.0706097104","volume":"104","author":"M Hedl","year":"2007","unstructured":"Hedl M, Li J, Cho JH, Abraham C. Chronic stimulation of Nod2 mediates tolerance to bacterial products. Proc Natl Acad Sci U S A. 2007;104(49):19440\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1212_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0016-5085(03)00661-9","volume":"125","author":"S Lala","year":"2003","unstructured":"Lala S, Ogura Y, Osborne C, Hor SY, Bromfield A, Davies S, Ogunbiyi O, Nunez G, Keshav S. Crohn\u2019s disease and the NOD2 gene: a role for Paneth cells. Gastroenterology. 2003;125(1):47\u201357.","journal-title":"Gastroenterology"},{"key":"1212_CR4","doi-asserted-by":"crossref","unstructured":"Yao Q. Nucleotide-binding oligomerization domain containing 2: Structure, function, and diseases. Semin Arthritis Rheum; 2013.","DOI":"10.1016\/j.semarthrit.2012.12.005"},{"issue":"7","key":"1212_CR5","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1097\/01.MIB.0000225332.83861.5f","volume":"12","author":"C Abraham","year":"2006","unstructured":"Abraham C, Cho JH. Functional consequences of NOD2 (CARD15) mutations. Inflamm Bowel Dis. 2006;12(7):641\u201350.","journal-title":"Inflamm Bowel Dis"},{"issue":"6837","key":"1212_CR6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/35079107","volume":"411","author":"JP Hugot","year":"2001","unstructured":"Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O\u2019Morain CA, Gassull M, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to crohn\u2019s disease. Nature. 2001;411(6837):599\u2013603.","journal-title":"Nature"},{"issue":"6","key":"1212_CR7","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1136\/gut.49.6.752","volume":"49","author":"DP McGovern","year":"2001","unstructured":"McGovern DP, van Heel DA, Ahmad T, Jewell DP. NOD2 (CARD15), the first susceptibility gene for crohn\u2019s disease. Gut. 2001;49(6):752\u20134.","journal-title":"Gut"},{"issue":"3","key":"1212_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/00054725-200108000-00014","volume":"7","author":"JH Cho","year":"2001","unstructured":"Cho JH. The Nod2 gene in crohn\u2019s disease: implications for future research into the genetics and immunology of crohn\u2019s disease. Inflamm Bowel Dis. 2001;7(3):271\u20135.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"1212_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ng720","volume":"29","author":"C Miceli-Richard","year":"2001","unstructured":"Miceli-Richard C, Lesage S, Rybojad M, Prieur AM, Manouvrier-Hanu S, Hafner R, Chamaillard M, Zouali H, Thomas G, Hugot JP. CARD15 mutations in Blau syndrome. Nat Genet. 2001;29(1):19\u201320.","journal-title":"Nat Genet"},{"issue":"11","key":"1212_CR10","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1002\/art.10618","volume":"46","author":"X Wang","year":"2002","unstructured":"Wang X, Kuivaniemi H, Bonavita G, Mutkus L, Mau U, Blau E, Inohara N, Nunez G, Tromp G, Williams CJ. CARD15 mutations in Familial granulomatosis syndromes: a study of the original Blau syndrome kindred and other families with large-vessel arteritis and cranial neuropathy. Arthritis Rheum. 2002;46(11):3041\u20135.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1212_CR11","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.jaad.2012.09.025","volume":"68","author":"Q Yao","year":"2013","unstructured":"Yao Q, Su LC, Tomecki KJ, Zhou L, Jayakar B, Shen B. Dermatitis as a characteristic phenotype of a new autoinflammatory disease associated with NOD2 mutations. J Am Acad Dermatol. 2013;68(4):624\u201331.","journal-title":"J Am Acad Dermatol"},{"issue":"25","key":"1212_CR12","doi-asserted-by":"publisher","first-page":"S0091","DOI":"10.1016\/j.jaci.2025.10.028","volume":"7","author":"S Wu","year":"2025","unstructured":"Wu S, Deng Z, Uddin A, Xin B, Gorevic P, Yao Q. Utilization of the All of Us Research Program in a study of genetics of Yao syndrome. J Allergy Clin Immunol 2025 Nov 7:S0091\u20136749(25)01118\u20132 https:\/\/doi.org\/10.1016\/j.jaci.2025.10.028. Online ahead of print.","journal-title":"J Allergy Clin Immunol."},{"issue":"5","key":"1212_CR13","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0022-3476(85)80394-2","volume":"107","author":"EB Blau","year":"1985","unstructured":"Blau EB. Familial granulomatous arthritis, iritis, and rash. J Pediatr. 1985;107(5):689\u201393.","journal-title":"J Pediatr"},{"issue":"3","key":"1212_CR14","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1182\/blood-2004-07-2972","volume":"105","author":"N Kanazawa","year":"2005","unstructured":"Kanazawa N, Okafuji I, Kambe N, Nishikomori R, Nakata-Hizume M, Nagai S, Fuji A, Yuasa T, Manki A, Sakurai Y, et al. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood. 2005;105(3):1195\u20137.","journal-title":"Blood"},{"issue":"11","key":"1212_CR15","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1136\/annrheumdis-2020-217320","volume":"79","author":"T Matsuda","year":"2020","unstructured":"Matsuda T, Kambe N, Ueki Y, Kanazawa N, Izawa K, Honda Y, Kawakami A, Takei S, Tonomura K, Inoue M, et al. Clinical characteristics and treatment of 50 cases of Blau syndrome in Japan confirmed by genetic analysis of the NOD2 mutation. Ann Rheum Dis. 2020;79(11):1492\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1212_CR16","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1093\/rheumatology\/keu437","volume":"54","author":"CD Rose","year":"2015","unstructured":"Rose CD, Pans S, Casteels I, Anton J, Bader-Meunier B, Brissaud P, Cimaz R, Espada G, Fernandez-Martin J, Hachulla E, et al. Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes. Rheumatology (Oxford). 2015;54(6):1008\u201316.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"1212_CR17","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1186\/ar4533","volume":"16","author":"K Ikeda","year":"2014","unstructured":"Ikeda K, Kambe N, Takei S, Nakano T, Inoue Y, Tomiita M, Oyake N, Satoh T, Yamatou T, Kubota T, et al. Ultrasonographic assessment reveals detailed distribution of synovial inflammation in Blau syndrome. Arthritis Res Ther. 2014;16(2):R89.","journal-title":"Arthritis Res Ther"},{"key":"1212_CR18","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ajo.2017.08.017","volume":"187","author":"IL Sarens","year":"2018","unstructured":"Sarens IL, Casteels I, Anton J, Bader-Meunier B, Brissaud P, Chedeville G, Cimaz R, Dick AD, Espada G, Fernandez-Martin J, et al. Blau Syndrome-Associated uveitis: preliminary results from an international prospective interventional case series. Am J Ophthalmol. 2018;187:158\u201366.","journal-title":"Am J Ophthalmol"},{"key":"1212_CR19","doi-asserted-by":"publisher","first-page":"895765","DOI":"10.3389\/fimmu.2022.895765","volume":"13","author":"T Matsuda","year":"2022","unstructured":"Matsuda T, Kambe N, Takimoto-Ito R, Ueki Y, Nakamizo S, Saito MK, Takei S, Kanazawa N. Potential benefits of TNF targeting therapy in Blau Syndrome, a NOD2-Associated systemic autoinflammatory granulomatosis. Front Immunol. 2022;13:895765.","journal-title":"Front Immunol"},{"issue":"1","key":"1212_CR20","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jaci.2021.05.030","volume":"149","author":"Y Kitagawa","year":"2022","unstructured":"Kitagawa Y, Kawasaki Y, Yamasaki Y, Kambe N, Takei S, Saito MK. Anti-TNF treatment corrects IFN-gamma-dependent Proinflammatory signatures in Blau syndrome patient-derived macrophages. J Allergy Clin Immunol. 2022;149(1):176\u2013e188177.","journal-title":"J Allergy Clin Immunol"},{"key":"1212_CR21","doi-asserted-by":"publisher","first-page":"1211240","DOI":"10.3389\/fimmu.2023.1211240","volume":"14","author":"Y Ueki","year":"2023","unstructured":"Ueki Y, Takimoto-Ito R, Saito MK, Tanizaki H, Kambe N. Tofacitinib, a suppressor of NOD2 expression, is a potential treatment for Blau syndrome. Front Immunol. 2023;14:1211240.","journal-title":"Front Immunol"},{"issue":"1","key":"1212_CR22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12969-021-00634-x","volume":"19","author":"S Zhang","year":"2021","unstructured":"Zhang S, Cai Z, Mo X, Zeng H. Tofacitinib effectiveness in Blau syndrome: a case series of Chinese paediatric patients. Pediatr Rheumatol Online J. 2021;19(1):160.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"3","key":"1212_CR23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.amjmed.2016.09.028","volume":"130","author":"Q Yao","year":"2017","unstructured":"Yao Q, Shen B. A Systematic Analysis of Treatment and Outcomes of NOD2-Associated Autoinflammatory Disease. Am J Med. 2017;130(3):365. e313\u2013365 e318.","journal-title":"Am J Med."},{"key":"1212_CR24","doi-asserted-by":"publisher","first-page":"1458118","DOI":"10.3389\/fimmu.2024.1458118","volume":"15","author":"H Nomani","year":"2024","unstructured":"Nomani H, Wu S, Saif A, Hwang F, Metzger J, Navetta-Modrov B, Gorevic PD, Aksentijevich I, Yao Q. Comprehensive clinical phenotype, genotype and therapy in Yao syndrome. Front Immunol. 2024;15:1458118.","journal-title":"Front Immunol"},{"key":"1212_CR25","doi-asserted-by":"publisher","first-page":"1304792","DOI":"10.3389\/fimmu.2024.1304792","volume":"15","author":"KA Williamson","year":"2024","unstructured":"Williamson KA, Samec MJ, Patel JA, Orandi AB, Wang B, Crowson CS, Loftus EV Jr., Alavi A, Moyer AM, Davis JM. 3rd: clinical phenotype, NOD2 genotypes, and treatment observations in Yao syndrome: a retrospective case series. Front Immunol. 2024;15:1304792.","journal-title":"Front Immunol"},{"key":"1212_CR26","doi-asserted-by":"publisher","first-page":"1521815","DOI":"10.3389\/fimmu.2024.1521815","volume":"15","author":"JM Davis III","year":"2024","unstructured":"Davis JM 3rd, McDonald C, Yao Q. Editorial: Basic, clinical, and translational studies of Yao syndrome and other NOD2 related diseases. Front Immunol. 2024;15:1521815.","journal-title":"Front Immunol"},{"key":"1212_CR27","doi-asserted-by":"publisher","first-page":"1342668","DOI":"10.3389\/fimmu.2024.1342668","volume":"15","author":"A Karamanakos","year":"2024","unstructured":"Karamanakos A, Vougiouka O, Sapountzi E, Venetsanopoulou AI, Tektonidou MG, Germenis AE, Sfikakis PP, Laskari K. The expanding clinical spectrum of autoinflammatory diseases with NOD2 variants: a case series and literature review. Front Immunol. 2024;15:1342668.","journal-title":"Front Immunol"},{"key":"1212_CR28","doi-asserted-by":"publisher","first-page":"1444542","DOI":"10.3389\/fimmu.2024.1444542","volume":"15","author":"J Zhang","year":"2024","unstructured":"Zhang J, Huang X, Shen M. Expanding clinical characteristics and genotypic profiling of Yao syndrome in Chinese patients. Front Immunol. 2024;15:1444542.","journal-title":"Front Immunol"},{"issue":"11","key":"1212_CR29","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1016\/j.jaip.2024.08.018","volume":"12","author":"S Cresoe-Ortiz","year":"2024","unstructured":"Cresoe-Ortiz S, Hall G, Randell RL, Lawrence MG, Patel A, Peroutka C, Yao Q, Mousallem T. Yao syndrome in a child with C2 deficiency. J Allergy Clin Immunol Pract. 2024;12(11):3159\u201362.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"11","key":"1212_CR30","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1093\/rheumatology\/ket143","volume":"52","author":"Q Yao","year":"2013","unstructured":"Yao Q, Schils J. Distal lower extremity swelling as a prominent phenotype of NOD2-associated autoinflammatory disease. Rheumatology (Oxford). 2013;52(11):2095\u20137.","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"1212_CR31","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1007\/s10620-025-09240-3","volume":"70","author":"JA Damianos","year":"2025","unstructured":"Damianos JA, Nehra AK, Murray JA, Loftus EV Jr., Davis JM 3rd, Nehra V. Gastrointestinal manifestations of Yao syndrome (NOD2-Associated autoinflammatory Disease). Dig Dis Sci. 2025;70(10):3453\u201364.","journal-title":"Dig Dis Sci"},{"issue":"2","key":"1212_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1080\/08916934.2019.1613382","volume":"52","author":"Q Yao","year":"2019","unstructured":"Yao Q, Li E, Shen B. Autoinflammatory disease with focus on NOD2-associated disease in the era of genomic medicine. Autoimmunity. 2019;52(2):48\u201356.","journal-title":"Autoimmunity"},{"key":"1212_CR33","doi-asserted-by":"publisher","first-page":"e365313","DOI":"10.1016\/j.amjmed.2016.09.028","volume":"130","author":"QSB Yao","year":"2017","unstructured":"Yao QSB. A systematic analysis of treatment and outcomes of NOD2-Associated autoinflammatory disease. Am J Med. 2017;130:e365313\u20138.","journal-title":"Am J Med"},{"issue":"1","key":"1212_CR34","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/ijd.17350","volume":"64","author":"MSS Shakhashiro","year":"2025","unstructured":"Shakhashiro MSS, Newcomer J, et al. Yao syndrome: A novel systemic autoinflammatory disease with cutaneous manifestations. Int J Dermatol. 2025;64(1):44\u201350.","journal-title":"Int J Dermatol"},{"key":"1212_CR35","doi-asserted-by":"crossref","unstructured":"Yao Q. Research letter: effectiveness of Canakinumab for the treatment of Yao syndrome patients. J Am Acad Dermatol. 2023; 88(3):653\u2013654.","DOI":"10.1016\/j.jaad.2019.09.020"},{"issue":"2","key":"1212_CR36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/08916934.2018.1442442","volume":"51","author":"C McDonald","year":"2018","unstructured":"McDonald C, Shen M, Johnson EE, Kabi A, Yao Q. Alterations in nucleotide-binding oligomerization domain-2 expression, pathway activation, and cytokine production in Yao syndrome. Autoimmunity. 2018;51(2):53\u201361.","journal-title":"Autoimmunity"},{"issue":"12","key":"1212_CR37","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1136\/ard-2024-225851","volume":"83","author":"B Fautrel","year":"2024","unstructured":"Fautrel B, Mitrovic S, De Matteis A, Bindoli S, Anton J, Belot A, Bracaglia C, Constantin T, Dagna L, Di Bartolo A, et al. EULAR\/PReS recommendations for the diagnosis and management of still\u2019s disease, comprising systemic juvenile idiopathic arthritis and adult-onset still\u2019s disease. Ann Rheum Dis. 2024;83(12):1614\u201327.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1212_CR38","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3899\/jrheum.2023-0995","volume":"51","author":"P Ruscitti","year":"2024","unstructured":"Ruscitti P, McGonagle D, Garcia VC, Rabijns H, Toennessen K, Chappell M, Edwards M, Miller P, Hansell N, Moss J, et al. Systematic review and metaanalysis of Pharmacological interventions in Adult-Onset still disease and the role of biologic disease-Modifying antirheumatic drugs. J Rheumatol. 2024;51(5):442\u201351.","journal-title":"J Rheumatol"},{"issue":"3","key":"1212_CR39","doi-asserted-by":"publisher","first-page":"502","DOI":"10.31138\/mjr.261224.erh","volume":"36","author":"GE Hasbani","year":"2025","unstructured":"Hasbani GE, Davis JM 3. Managing Yao syndrome: A case of beneficial treatment with Upadacitinib and Leflunomide. Mediterr J Rheumatol. 2025;36(3):502\u20134.","journal-title":"Mediterr J Rheumatol"},{"issue":"Suppl A","key":"1212_CR40","doi-asserted-by":"publisher","first-page":"A5","DOI":"10.1155\/2005\/269076","volume":"19","author":"MS Silverberg","year":"2005","unstructured":"Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, Caprilli R, Colombel JF, Gasche C, Geboes K, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal world Congress of gastroenterology. Can J Gastroenterol. 2005;19(Suppl A):A5\u201336.","journal-title":"Can J Gastroenterol"},{"issue":"2","key":"1212_CR41","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.gie.2024.08.034","volume":"101","author":"AIEC Panel","year":"2025","unstructured":"Panel AIEC, Shen B, Abreu MT, Cohen ER, Farraye FA, Fischer M, Feuerstadt P, Kapur S, Ko HM, Kochhar GS, et al. Endoscopic diagnosis and management of adult inflammatory bowel disease: a consensus document from the American society for Gastrointestinal endoscopy IBD endoscopy consensus panel. Gastrointest Endosc. 2025;101(2):295\u2013314.","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"1212_CR42","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2478\/rir-2022-0012","volume":"3","author":"A Barkhodari","year":"2022","unstructured":"Barkhodari A, Lee KE, Shen M, Shen B, Yao Q. Inflammatory bowel disease: focus on enteropathic arthritis and therapy. Rheumatol Immunol Res. 2022;3(2):69\u201376.","journal-title":"Rheumatol Immunol Res"},{"key":"1212_CR43","doi-asserted-by":"crossref","unstructured":"Appiah JK, Hayat U, Garg N, Asante R, Donneyong E, Haider MU, Patel P, Khan Z, Siddiqui AA. Emerging therapies in inflammatory bowel disease: a comprehensive review. J Clin Med 2025;14(17):6119.","DOI":"10.3390\/jcm14176119"},{"issue":"7","key":"1212_CR44","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41584-021-00614-1","volume":"17","author":"I Aksentijevich","year":"2021","unstructured":"Aksentijevich I, Schnappauf O. Molecular mechanisms of phenotypic variability in Monogenic autoinflammatory diseases. Nat Rev Rheumatol. 2021;17(7):405\u201325.","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"1212_CR45","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1086\/339432","volume":"70","author":"S Lesage","year":"2002","unstructured":"Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O\u2019Morain C, Gassull M, Binder V, et al. CARD15\/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet. 2002;70(4):845\u201357.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"1212_CR46","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.gtc.2017.05.002","volume":"46","author":"MH Wang","year":"2017","unstructured":"Wang MH, Picco MF. Crohn\u2019s disease: genetics update. Gastroenterol Clin North Am. 2017;46(3):449\u201361.","journal-title":"Gastroenterol Clin North Am"},{"issue":"1","key":"1212_CR47","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13075-024-03286-w","volume":"26","author":"J Zhang","year":"2024","unstructured":"Zhang J, Luo Y, Wu B, Huang X, Zhao M, Wu N, Miao J, Li J, Zhu L, Wu D, et al. Identifying functional dysregulation of NOD2 variant Q902K in patients with Yao syndrome. Arthritis Res Ther. 2024;26(1):58.","journal-title":"Arthritis Res Ther"},{"key":"1212_CR48","doi-asserted-by":"crossref","unstructured":"Yao Q, Gorevic P, Shen B, Gibson G. Genetically transitional disease: a new concept in genomic medicine. Trends Genet. 2023;39(2):98\u2013108.","DOI":"10.1016\/j.tig.2022.11.002"},{"issue":"5","key":"1212_CR49","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41584-024-01086-9","volume":"20","author":"TB Niewold","year":"2024","unstructured":"Niewold TB, Aksentijevich I, Gorevic PD, Gibson G, Yao Q. Genetically transitional disease: conceptual Understanding and applicability to rheumatic disease. Nat Rev Rheumatol. 2024;20(5):301\u201310.","journal-title":"Nat Rev Rheumatol"},{"key":"1212_CR50","doi-asserted-by":"crossref","unstructured":"Yao Q, Gorevic PD, Gibson G. Genetically transitional disease and the road to personalized medicine. Genes (Basel). 2025;16(4):401","DOI":"10.3390\/genes16040401"},{"issue":"1","key":"1212_CR51","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13073-023-01244-w","volume":"15","author":"C Astore","year":"2023","unstructured":"Astore C, Sharma S, Nagpal S, Consortium NIG, Cutler DJ, Rioux JD, Cho JH, McGovern DPB, Brant SR, Kugathasan S, et al. The role of admixture in the rare variant contribution to inflammatory bowel disease. Genome Med. 2023;15(1):97.","journal-title":"Genome Med"},{"key":"1212_CR52","doi-asserted-by":"publisher","first-page":"1265404","DOI":"10.3389\/fimmu.2023.1265404","volume":"14","author":"H Nomani","year":"2023","unstructured":"Nomani H, Deng Z, Navetta-Modrov B, Yang J, Yun M, Aroniadis O, Gorevic P, Aksentijevich I, Yao Q. Implications of combined NOD2 and other gene mutations in autoinflammatory diseases. Front Immunol. 2023;14:1265404.","journal-title":"Front Immunol"},{"issue":"5","key":"1212_CR53","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1053\/j.gastro.2010.07.006","volume":"139","author":"CR Homer","year":"2010","unstructured":"Homer CR, Richmond AL, Rebert NA, Achkar JP, McDonald C. ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in crohn\u2019s disease pathogenesis. Gastroenterology. 2010;139(5):1630\u201341. 1641.e.","journal-title":"Gastroenterology"},{"issue":"2","key":"1212_CR54","doi-asserted-by":"publisher","first-page":"e0213108","DOI":"10.1371\/journal.pone.0213108","volume":"14","author":"E Li","year":"2019","unstructured":"Li E, Zhang Y, Tian X, Wang X, Gathungu G, Wolber A, Shiekh SS, Sartor RB, Davidson NO, Ciorba MA, et al. Influence of crohn\u2019s disease related polymorphisms in innate immune function on ileal Microbiome. PLoS ONE. 2019;14(2):e0213108.","journal-title":"PLoS ONE"},{"issue":"10","key":"1212_CR55","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.3748\/wjg.v20.i10.2664","volume":"20","author":"SCS Wolfkamp","year":"2014","unstructured":"Wolfkamp SCS. ATG16L1\u2009andNOD2polymorphisms enhance phagocytosis in mono cytes of crohn\u2019s disease patients. World J Gastroenterol. 2014;20(10):2664.","journal-title":"World J Gastroenterol"},{"issue":"18","key":"1212_CR56","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1016\/j.febslet.2014.07.029","volume":"588","author":"R Parkhouse","year":"2014","unstructured":"Parkhouse R, Boyle JP, Monie TP. Blau syndrome polymorphisms in NOD2 identify nucleotide hydrolysis and helical domain 1 as signalling regulators. FEBS Lett. 2014;588(18):3382\u20139.","journal-title":"FEBS Lett"},{"issue":"1","key":"1212_CR57","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12969-022-00743-1","volume":"20","author":"S-Y Chang","year":"2022","unstructured":"Chang S-Y, Kambe N, Fan W-L, Huang J-L, Lee W-I, Wu C-Y. Incomplete penetrance of NOD2 C483W mutation underlining Blau syndrome. Pediatr Rheumatol. 2022;20(1):86.","journal-title":"Pediatr Rheumatol"},{"issue":"1","key":"1212_CR58","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nm.2069","volume":"16","author":"R Cooney","year":"2009","unstructured":"Cooney R, Baker J, Brain O, Danis B, Pichulik T, Allan P, Ferguson DJP, Campbell BJ, Jewell D, Simmons A. NOD2 stimulation induces autophagy in dendritic cells influencing Bact Erial handling and antigen presentation. Nat Med. 2009;16(1):90\u20137.","journal-title":"Nat Med"},{"key":"1212_CR59","doi-asserted-by":"crossref","unstructured":"Khan N, Vidyarthi A, Pahari S, Negi S, Aqdas M, Nadeem S, Agnihotri T, Agrewala JN. Signaling through NOD-2 and TLR-4 bolsters the T cell priming capabili Ty of dendritic cells by inducing autophagy. Sci Rep. 2016;6(1):27263.","DOI":"10.1038\/srep19084"},{"issue":"16","key":"1212_CR60","doi-asserted-by":"publisher","first-page":"8946","DOI":"10.1128\/JVI.01110-14","volume":"88","author":"C Lupfer","year":"2014","unstructured":"Lupfer C, Thomas PG, Kanneganti T-D. Nucleotide oligomerization and binding domain 2-Dependent dendritic Ce Ll activation is necessary for innate immunity and optimal CD8\u2009<\u2009sup>+\u2009T cell responses to influenza A virus infection. J Virol. 2014;88(16):8946\u201355.","journal-title":"J Virol"},{"issue":"4","key":"1212_CR61","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1189\/jlb.0805484","volume":"79","author":"M Kramer","year":"2006","unstructured":"Kramer M, Netea MG, de Jong DJ, Kullberg BJ, Adema GJ. Impaired dendritic cell function in crohn\u2019s disease patients with NOD2 3020insC mutation. J Leukoc Biol. 2006;79(4):860\u20136.","journal-title":"J Leukoc Biol"},{"issue":"2","key":"1212_CR62","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.crohns.2007.08.006","volume":"1","author":"M Butler","year":"2007","unstructured":"Butler M, Chaudhary R, van Heel DA, Playford RJ, Ghosh S. NOD2 activity modulates the phenotype of LPS-stimulated dendritic cell s to promote the development of T-helper type 2-like lymphocytes \u2014 Pos sible implications for NOD2-associated crohn\u2019s disease. J Crohn\u2019s Colitis. 2007;1(2):106\u201315.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"11","key":"1212_CR63","doi-asserted-by":"publisher","first-page":"7925","DOI":"10.4049\/jimmunol.181.11.7925","volume":"181","author":"JG Magalhaes","year":"2008","unstructured":"Magalhaes JG, Le Fritz JrH L, Sellge G, Travassos LH, Selvanantham T, Girardin SE, Gommerman JL, Philpott DJ. Nod2-Dependent Th2 polarization of Antigen-Specific immunity. J Immunol. 2008;181(11):7925\u201335.","journal-title":"J Immunol"},{"issue":"3","key":"1212_CR64","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.clim.2009.05.005","volume":"134","author":"A Borzutzky","year":"2010","unstructured":"Borzutzky A, Fried A, Chou J, Bonilla FA, Kim S, Dedeoglu F. NOD2-associated diseases: bridging innate immunity and autoinflammatio n. Clin Immunol. 2010;134(3):251\u201361.","journal-title":"Clin Immunol"},{"issue":"4","key":"1212_CR65","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jaci.2012.02.004","volume":"129","author":"CEI Janssen","year":"2012","unstructured":"Janssen CEI, Rose CD, De Hertogh G, Martin TM, Bader Meunier B, Cimaz R, Harjacek M, Quartier P, Ten Cate R, Thomee C, et al. Morphologic and immunohistochemical characterization of granulomas in the nucleotide oligomerization domain 2\u2013related disorders Blau syndrom e and Crohn disease. J Allergy Clin Immunol. 2012;129(4):1076\u201384.","journal-title":"J Allergy Clin Immunol"},{"issue":"Supplement1","key":"1212_CR66","doi-asserted-by":"publisher","first-page":"5808","DOI":"10.4049\/jimmunol.208.Supp.58.08","volume":"208","author":"K Koney","year":"2022","unstructured":"Koney K, Lashley SJ, Lee EJ, Vance EE, Philpott DJ, Dugan JW, Davey MM, Rosenzweig HL, Napier RJ. T cell intrinsic Nod2 controls Th17 immunity to <\u2009i>Candida albicans\u2009infection. J Immunol. 2022;208(Supplement1):5808\u20135808.","journal-title":"J Immunol"},{"issue":"Supplement1","key":"1212_CR67","first-page":"159101","volume":"208","author":"RJ Napier","year":"2022","unstructured":"Napier RJ, Vance EE, Koney KV, Lee EJ, Davey MM, Rosenzweig HL. T cell intrinsic role for NOD2 in Blau syndrome. J Immunol. 2022;208(Supplement1):159101\u2013159101.","journal-title":"J Immunol"},{"issue":"1","key":"1212_CR68","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/imr.12902","volume":"297","author":"BC Trindade","year":"2020","unstructured":"Trindade BC, Chen GY. NOD1 and NOD2 in inflammatory and infectious diseases. Immunol Rev. 2020;297(1):139\u201361.","journal-title":"Immunol Rev"},{"issue":"4","key":"1212_CR69","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/JLB.2RU0718-290R","volume":"105","author":"MV Pashenkov","year":"2019","unstructured":"Pashenkov MV, Murugina NE, Budikhina AS, Pinegin BV. Synergistic interactions between NOD receptors and tlrs: mechanisms and clinical implications. J Leukoc Biol. 2019;105(4):669\u201380.","journal-title":"J Leukoc Biol"},{"issue":"43","key":"1212_CR70","doi-asserted-by":"publisher","first-page":"17537","DOI":"10.1073\/pnas.1202870109","volume":"109","author":"J Kleinnijenhuis","year":"2012","unstructured":"Kleinnijenhuis J, Quintin J, Preijers F, Joosten LA, Ifrim DC, Saeed S, Jacobs C, van Loenhout J, de Jong D, Stunnenberg HG, et al. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci U S A. 2012;109(43):17537\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1212_CR71","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/imr.12193","volume":"260","author":"W Strober","year":"2014","unstructured":"Strober W, Asano N, Fuss I, Kitani A, Watanabe T. Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in crohn\u2019s disease. Immunol Rev. 2014;260(1):249\u201360.","journal-title":"Immunol Rev"},{"issue":"3","key":"1212_CR72","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1172\/JCI30587","volume":"117","author":"W Strober","year":"2007","unstructured":"Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest. 2007;117(3):514\u201321.","journal-title":"J Clin Invest"},{"key":"1212_CR73","doi-asserted-by":"publisher","first-page":"988862","DOI":"10.3389\/fimmu.2022.988862","volume":"13","author":"L Mao","year":"2022","unstructured":"Mao L, Dhar A, Meng G, Fuss I, Montgomery-Recht K, Yang Z, Xu Q, Kitani A, Strober W. Blau syndrome NOD2 mutations result in loss of NOD2 cross-regulatory function. Front Immunol. 2022;13:988862.","journal-title":"Front Immunol"},{"issue":"6","key":"1212_CR74","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1038\/mi.2014.19","volume":"7","author":"T Watanabe","year":"2014","unstructured":"Watanabe T, Asano N, Meng G, Yamashita K, Arai Y, Sakurai T, Kudo M, Fuss IJ, Kitani A, Shimosegawa T, et al. NOD2 downregulates colonic inflammation by IRF4-mediated Inhibition of K63-linked polyubiquitination of RICK and TRAF6. Mucosal Immunol. 2014;7(6):1312\u201325.","journal-title":"Mucosal Immunol"},{"issue":"2","key":"1212_CR75","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/intimm\/dxac045","volume":"35","author":"Y Masuta","year":"2023","unstructured":"Masuta Y, Minaga K, Kurimoto M, Sekai I, Hara A, Omaru N, Okai N, Otsuka Y, Takada R, Yoshikawa T, et al. Activation of nucleotide-binding oligomerization domain 2 by Muramyl dipeptide negatively regulates Toll-like receptor 9-mediated colonic inflammation through the induction of deubiquitinating enzyme A expression. Int Immunol. 2023;35(2):79\u201394.","journal-title":"Int Immunol"},{"issue":"10","key":"1212_CR76","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/ni.1782","volume":"10","author":"A Sabbah","year":"2009","unstructured":"Sabbah A, Chang TH, Harnack R, Frohlich V, Tominaga K, Dube PH, Xiang Y, Bose S. Activation of innate immune antiviral responses by Nod2. Nat Immunol. 2009;10(10):1073\u201380.","journal-title":"Nat Immunol"},{"issue":"1","key":"1212_CR77","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/ni.1823","volume":"11","author":"LH Travassos","year":"2010","unstructured":"Travassos LH, Carneiro LA, Ramjeet M, Hussey S, Kim YG, Magalhaes JG, Yuan L, Soares F, Chea E, Le Bourhis L, et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol. 2010;11(1):55\u201362.","journal-title":"Nat Immunol"},{"issue":"11","key":"1212_CR78","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1080\/15548627.2022.2039991","volume":"18","author":"P Gao","year":"2022","unstructured":"Gao P, Liu H, Huang H, Sun Y, Jia B, Hou B, Zhou X, Strober W, Zhang F. The Crohn Disease-associated ATG16L1(T300A) polymorphism regulates inflammatory responses by modulating TLR- and NLR-mediated signaling. Autophagy. 2022;18(11):2561\u201375.","journal-title":"Autophagy"},{"issue":"1","key":"1212_CR79","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.brainresrev.2008.12.020","volume":"60","author":"K Ren","year":"2009","unstructured":"Ren K, Torres R. Role of interleukin-1beta during pain and inflammation. Brain Res Rev. 2009;60(1):57\u201364.","journal-title":"Brain Res Rev"},{"issue":"30","key":"1212_CR80","doi-asserted-by":"publisher","first-page":"26440","DOI":"10.1074\/jbc.M111.237495","volume":"286","author":"M Hedl","year":"2011","unstructured":"Hedl M, Abraham C. Distinct roles for Nod2 protein and autocrine interleukin-1beta in Muramyl dipeptide-induced mitogen-activated protein kinase activation and cytokine secretion in human macrophages. J Biol Chem. 2011;286(30):26440\u20139.","journal-title":"J Biol Chem"},{"issue":"22","key":"1212_CR81","doi-asserted-by":"publisher","first-page":"7803","DOI":"10.1073\/pnas.0802726105","volume":"105","author":"LC Hsu","year":"2008","unstructured":"Hsu LC, Ali SR, McGillivray S, Tseng PH, Mariathasan S, Humke EW, Eckmann L, Powell JJ, Nizet V, Dixit VM, et al. A NOD2-NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and Muramyl dipeptide. Proc Natl Acad Sci U S A. 2008;105(22):7803\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1212_CR82","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s13578-023-01188-z","volume":"13","author":"L Ji","year":"2023","unstructured":"Ji L, Li T, Chen H, Yang Y, Lu E, Liu J, Qiao W, Chen H. The crucial regulatory role of type I interferon in inflammatory diseases. Cell Biosci. 2023;13(1):230.","journal-title":"Cell Biosci"},{"issue":"13","key":"1212_CR83","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1084\/jem.20101326","volume":"207","author":"JM Gonzalez-Navajas","year":"2010","unstructured":"Gonzalez-Navajas JM, Law J, Nguyen KP, Bhargava M, Corr MP, Varki N, Eckmann L, Hoffman HM, Lee J, Raz E. Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production. J Exp Med. 2010;207(13):2799\u2013807.","journal-title":"J Exp Med"},{"issue":"6289","key":"1212_CR84","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1126\/science.aad9948","volume":"352","author":"H Chu","year":"2016","unstructured":"Chu H, Khosravi A, Kusumawardhani IP, Kwon AH, Vasconcelos AC, Cunha LD, Mayer AE, Shen Y, Wu WL, Kambal A, et al. Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease. Science. 2016;352(6289):1116\u201320.","journal-title":"Science"},{"key":"1212_CR85","doi-asserted-by":"crossref","unstructured":"Vasquez Ayala A, Hsu CY, Oles RE, Matsuo K, Loomis LR, Buzun E, Carrillo Terrazas M, Gerner RR, Lu HH, Kim S et al. Commensal bacteria promote type I interferon signaling to maintain immune tolerance in mice. J Exp Med. 2024;221(1):e20230063.","DOI":"10.1084\/jem.20230063"},{"issue":"4","key":"1212_CR86","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.immuni.2007.08.013","volume":"27","author":"AJ van Beelen","year":"2007","unstructured":"van Beelen AJ, Zelinkova Z, Taanman-Kueter EW, Muller FJ, Hommes DW, Zaat SA, Kapsenberg ML, de Jong EC. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity. 2007;27(4):660\u20139.","journal-title":"Immunity"},{"issue":"4","key":"1212_CR87","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.immuni.2009.02.007","volume":"30","author":"Y Chung","year":"2009","unstructured":"Chung Y, Chang SH, Martinez GJ, Yang XO, Nurieva R, Kang HS, Ma L, Watowich SS, Jetten AM, Tian Q, et al. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity. 2009;30(4):576\u201387.","journal-title":"Immunity"},{"issue":"5","key":"1212_CR88","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1172\/JCI21404","volume":"116","author":"D Yen","year":"2006","unstructured":"Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, McKenzie B, Kleinschek MA, Owyang A, Mattson J, Blumenschein W, et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest. 2006;116(5):1310\u20136.","journal-title":"J Clin Invest"},{"issue":"7","key":"1212_CR89","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.4049\/jimmunol.1700507","volume":"201","author":"RJ Napier","year":"2018","unstructured":"Napier RJ, Lee EJ, Vance EE, Snow PE, Samson KA, Dawson CE, Moran AE, Stenzel P, Davey MP, Sakaguchi S, et al. Nod2 deficiency augments Th17 responses and exacerbates autoimmune arthritis. J Immunol. 2018;201(7):1889\u201398.","journal-title":"J Immunol"},{"issue":"1","key":"1212_CR90","doi-asserted-by":"publisher","first-page":"5406","DOI":"10.1038\/s41467-020-18961-0","volume":"11","author":"RJ Napier","year":"2020","unstructured":"Napier RJ, Lee EJ, Davey MP, Vance EE, Furtado JM, Snow PE, Samson KA, Lashley SJ, Brown BR, Horai R, et al. T cell-intrinsic role for Nod2 in protection against Th17-mediated uveitis. Nat Commun. 2020;11(1):5406.","journal-title":"Nat Commun"},{"issue":"6","key":"1212_CR91","doi-asserted-by":"publisher","first-page":"e378","DOI":"10.1016\/S2665-9913(25)00005-0","volume":"7","author":"Q Yao","year":"2025","unstructured":"Yao Q. The same genotype gives rise to a spectrum of disorders. Lancet Rheumatol. 2025;7(6):e378\u20139.","journal-title":"Lancet Rheumatol"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-026-01212-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-026-01212-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-026-01212-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T09:08:26Z","timestamp":1770887306000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-026-01212-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1212"],"URL":"https:\/\/doi.org\/10.1007\/s11926-026-01212-4","relation":{},"ISSN":["1534-6307"],"issn-type":[{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain studies performed with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5"}}